Summary
We studied the utility of a trial multivitamin preparation ' NK-041' for total parenteral nutrition. The alimentation modality generally called total parenteral nutrition (TPN) or intravenous hyperalimentation has recently came into wide use in clinical medicine , particularly in surgery. Dudrick et al. (1) first employed this method in 1968 in patients with whom difficulty was experienced in oral administration, TPN is achieved by feeding a hypertonic glucose solution, amino acids , fats, electrolytes, trace elements and vitamins through a catheter placed in the central vein , a procedure called hyperalimentation. This can supply the whole daily nutritional requirement and has contributed greatly to the maintenance of nutrition before and after surgical intervention.
Inasmuch as the patient receiving TPN depends totally on hyperalimentation for nutritional supply, the solution for TPN ought to contain all required nutrients at sufficiently high levels. The recipes for nutrients other than vitamins seem to be well established from past clinical investigations, whereas no absolute recipe for vitamins is available because of the paucity of studies. Avitaminosis has been observed even in patients receiving TPN (2, 3) , and the establishment of an adequate recipe for vitamins is essential.
In the United States of America, a multivitamin preparation for intravenous use has been available under the trade name of 'MVI' (US Vitamin Pharm . Co.) since 1953, and has also been used for TPN. A similar preparation has recently become available in Japan. In 1975, the American Medical Association (AMA) drew up guidelines for multvitamin preparations to be used in TPN (4) . Meng (S), Jeejeebhoy et al. (2) and Nichoalds et al. (6) proposed their own recipes for the same purpose, while in Japan recipes for hospital use were first arrived at by the group at Osaka University Hospital in 1979, these being IVH-VX (7) and its modification PV-123 (7). In 1982, Okuda et al. (8) recommended a new vitamin recipe for TPN based on the information and data available and discussions by a group of prominent Japanese vitamin specialists. Based on their recommendation, which seemed most reliable, we made a trial multivitamin preparation for TPN and called it 'NK-041.' This preparation was administered to 300 surgical patients in the form of TPN, and changes in the blood levels of individual vitamins were followed . There were 40 dropouts, and the results obtained in 260 patients will now be described .
EXPERIMENTAL
Composition of NK-041 and administration to patients Table 1 gives the composition of NK-041 used in this study . It is provided as a kit composed of Preparations I, II and III: Preparation I contains vitamins B2 , B6 and C, biotin and pantothenic acid; Preparation II, vitamins B1 , B12, nicotinic acid and folic acid; and Preparation III, vitamins A, D2, E and K1. For TPN, these preparations are first mixed with a suitable amino acid solution or a hypertonic glucose solution, and then administered by intravenous infusion over 6 to 24h. To prevent photodegradation of vitamins during the administration, the fluid container was covered by an orange vinyl sheet. As a rule, patients received TPN for more Subjects and patients studied Normal subjects. Blood samples were collected from 59 healthy adult volunteers from office and laboratory workers. Of these, 36 were male, 23 were female, 11 (6 males and 5 females) were aged in their 20s, 12 (6 and 6) in their 30s, 13 (7 and 6) in their 40s, 14 (8 and 6) in their 50s, and 9 (males) in their 60s. Blood withdrawal was done early in the morning before breakfast. This study was made during the period 1981-1982.
Surgical patients receiving TPN. Blood was also collected from 300 surgical patients receiving TPN. However, samples from 40 patients were eventually discarded as they did not meet the requirements, and 260 patients were finally used in this study. Blood samples were obtained at the medical centers listed in Table 2 Measurement of blood vitamin levels Table 3 gives the methods for measuring blood vitamins used in this study . Since vitamin D is rapidly metabolized in vivo into 25-hydroxyvitamin D (25-OH -D) which is known as its major circulating metabolite (9), the metabolite was determined instead of vitamin D itself. Exogenous 25-OH-D2 derived from vitamin D2 in NK-041 and endogenous 25-OH-D3 derived from vitamin D3 photo synthesized in the skin were simultaneously determined according to the method of Okano et al. (10) . Since there is not adequate assay method for vitamin K1 in plasma, the prothrombin time was determined as an indirect measure of vitamin K1. For vitamin B1, the thiamine pyrophosphate (TPP) effect (13) was measured in addition to the assay of the vitamin itself.
Time of blood vitamin measurement In patients operated on, blood vitamin levels were measured preoperatively, at 1-week intervals starting 1 week postoperative up to 4 weeks, at 2-week intervals thenceforth, and monthly from 3 months onward. If the patients were not eventually operated on, blood vitamin levels were assayed just before the start of TPN, and thereafter at intervals identical to those used in the operated patients. For each assay, blood was collected at a time when each kit had already been administered and shortly before a new kit was given.
Laboratory studies
Routine hematological examinations, liver function tests, and measurement of serum electrolytes were done weekly during TPN. At the same time, particular attention was paid to detect clinically signs of avitaminosis and hypervitaminosis while subjective and objective symptoms were monitored in the patients.
Evaluation of utility of NK-041
1. The effect of TPN with NK-041 on the nutritional status of patients was evaluated from whether it was 'improved,' 'unchanged' or 'aggravated. ' 2. Clinical manifestations of avitaminosis or hypervitaminosis were looked for.
3. Side-effects attributable to NK-041 were assessed from clinical manifes tations and laboratory findings.
4. Blood vitamin levels were determined, and compared with the respective data in normal subjects.
5. From these observations, overall evaluation was made as to whether or not NK-0.41 was adequate as a multivitamin preparation for TPN.
RESULTS
Blood vitamin levels in normal subjects Table 4 gives the blood vitamin levels assayed in 59 normal subjects. They were used as the normal reference values.
Changes in fat-soluble vitamin levels
The mean of vitamin A measurements before TPN was below normal, and it tended to increase gradually during TPN with NK-041, but it did not reach the lower normal limit within 8 weeks (Fig. la) . When the pretreatment levels were divided into low, normal and high groups, the low group constituted a large exposure to sunlight. In contrast, plasma levels of exogenous 25-OH-D2 derived from vitamin D2 in NK-041 rapidly increased following TPN. Figures 4a and 4b represent variations in 25-OH-D3 and 25-OH-D2 levels in plasma in patients with and without operations, respectively. There was no significant difference in plasma 25-OH-D3 between the two groups ( Fig. 4a) , whereas 25-OH-D2 levels in patients operated on were significantly lower than the corresponding data in non-operated patients (Fig. 4b) . The prothrombin time was determined as an index of vitamin K activity. The data in 25 patients who received antibiotics and in 19 who were given additional vitamin K1 were excluded. The results demonstrated that prothrombin time varied within the normal range during TPN.
Changes in water-soluble vitamin levels
Changes in blood levels of water-soluble vitamins in these patients are shown in Figs. 5a-i. The vitamin B1 levels were normal during TPN. The TPP effect as another index of B1 activity also varied within the normal limits. The levels of vitamin B2 in whole blood and B6 in plasma also remained within the respective normal ranges (Figs. 5b and 5c ). Plasma vitamin B12 levels were already higher than normal before TPN, and these high values continued during TPN (Fig. 5d) , Since the half-life of vitamin Bit in about 1 year, which is far greater than the half-lives for other water-soluble vitamins, and many patients had already received this vitamin before TPN, such high pre-TPN values were not unexpected. The levels of vitamin C, nicotinic acid, pantothenic acid and folic acid in plasma were within the respective normal limits throughout the study period (Figs. 5e-h). The measured plasma biotin levels are given in Fig. 5i . They were lower than normal before TPN, reached the normal range, and gradually declined during TPN. Subjective and objective symptoms Since 200 patients (77%) had malignancies of the digestive tract, manifestations related to the alimentary tract such as nausea, vomit, fulness of the abdomen, and diarrhea, were not uncommon. During TPN, 19 such manifestations were evaluated as being 'aggravated,' but this was due to the underlying disease rather than due to TPN. The majority of patients (236/260) were operated upon, and anemia was seen in 28. The anemia in 11 of them was evaluated to be aggravated, yet this was not due to deficiency of vitamin B12 or folate. No patient was found to have signs of avitaminosis such as night blindness, dermatitis, keratosis or gingival bleed during TPN.
Evaluation of utility of NK-041
Evaluation was made of the utility of NK-041 in TPN according to the criteria given in the MATERIALS AND METHODS. The numbers of patients evaluated as 
DISCUSSION
In 1977, AMA drafted guidelines for the composition of multivitamin prepara tions for TPN (4) . However, as stated by Dr. Shils (11) , who was a member of the responsible committee, some parts of the guidelines were not based on experimental data, and were presumptive. Therefore, matters were far from settled, and further investigations were called for. Very little is known today about precisely what vitamins and just how much of them are necessary for treating various diseases and clinical manifestations. From such considerations, a trial multivitamin preparation for the purpose of TPN, tentatively named NK-041, was made according to Okuda et al. (8) , and was given to about 300 surgical patients receiving TPN (40 of them were eventually excluded); changes in blood vitamin levels and subjective and objective signs were assessed and laboratory tests were conducted. The assayed values of vitamins in these patients were compared with the respective normal values.
Excessive doses of vitamin A lead to hypervitaminosis as it accumulates in the liver and has a relatively long haft-life (200-300days). Since administration of vitamin A is usually constant in TPN, attention should be drawn to possible overdosing. In this study, most of the patients (108/139) showed plasma levels lower than normal before TPN. The levels gradually increased and reached the lower limit of normal during TPN. Although it is ideal to give greater amounts of vitamin A to patients with low starting levels, the daily dose of 3,300 IU contained in NK-041 seems sufficient for the maintenance of appropriate levels of vitamin A, because the plasma levels in these low-group patients came near the lower normal limit and the half-life of vitamin A is longer than that of other vitamins.
Inasmuch as vitamin E has a more rapid metabolic turnover compared to other fat-soluble vitamins, there is less risk of hypervitaminosis. Therefore, it was thought that a daily dose of 15mg of this vitamin would be more useful than the suggested dose of 10mg/day in the AMA guidelines (4). The pre-TPN plasma levels of vitamin E in 98 patients among 141 studied were lower than normal, and they increased gradually to attain levels above the lower normal limit during TPN. Thus, our recommendation of 15mg for daily intake seems reasonable. The plasma vitamin E levels in patients receiving a fat emulsion were significantly lower than in those not receiving it after 6weeks of TPN. Usually, a fat emulsion is used in TPN as an adjunct to glucose, and therefore sufficient amounts of vitamin E are desirable. These considerations also warrant a daily dose of 15mg.
As evident from Fig. 2a , plasma vitamin A is decreased in cancer patients, particularly in patients with carcinoma of the liver and pancreas. According to Muto (12) , the content of vitamin A in liver cancer tissue surgically removed was considerably lower compared with the surrounding noncancerous parenchyma cells. He also observed in experimentally produced liver cancer in mice that vitamin A rapidly decreased in cells from the precancerous stage onward. These findings suggest an increase in vitamin A consumption in cancer patients. Our results are compatible with this view. Much more vitamin A may be necessary in TPN for cancer patients, a very important problem yet to be solved. A similar relationship exists between plasma vitamin E levels and various malignancies, as shown in Fig.  2b .
Most patients receiving TPN have little exposure to sunlight, as they remain in BLOOD   VITAMIN  LEVELS  DURING  TPN  19 hospital. Expectedly, endogenous 25-OH-D3 derived from vitamin D3 photo synthesized in the skin gradually declined, and the plasma levels were lowered below 5ng/ml after 8 weeks (Fig. 3a) . By contrast, the exogenous 25-OH-D2 coming from vitamin D2 provided by NK-04l rapidly increased (Fig. 3b) . Since the half-life of 25-OH-D is shorter (20-30days) than that of vitamin A, and the risk of producing hypervitaminosis is much less, it was felt that our recommended daily dose of 400 IU of vitamin D2 was more practical than the 200 IU/day in the AMA guide lines (4) . As shown in Fig. 4b , plasma 25-OH-D2 levels in patients undergoing a surgery were significantly lower than those in patients who had no operation. This suggests an increased consumption of vitamin D due to operation, but this needs confirmation in the future with elucidation of the mechanism whereby it occurs. Since water-soluble vitamins are generally lost from the body rapidly, they carry much less risk of overdosage. Therefore, NK-041 contained, as a rule, twice the recommended dietary allowance of water-soluble vitamins. The plasma levels of these vitamins remained within the normal ranges in our patients except for those of vitamin B12 whose pre-TPN levels were higher than normal.
Anemia was not uncommon among those who had major operations, yet there was no indication of deficiency in hemopoietic vitamins, B12 and follate. Factors other than these vitamins seem to be involved in such anemia. During TPN, neither avitaminosis nor hypervitaminosis was observed. Laboratory studies on these patients demonstrated no particular abnormalities during TPN, and neither hypervitaminosis nor side-effects attributable to NK-041 was observed. Most patients (257/260) were evaluated as 'improved' or 'unchanged' in their nutritional status. From these results and observations, it is concluded that a recipe of NK-041 as a multivitamin preparation is useful for TPN, having no untoward side-effects. 
